Patent ID: 11951082
Assignee: FORD THERAPEUTICS, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 16:
17. A medicinal composition for reducing the time period necessary to treat lesions caused by cold sores or herpes comprising:
(a) a 4% solution of chlorhexidine gluconate as the sole antiviral agent acting against cold sores or herpes virus in an amount of from about 1 to about 20 weight percent;
(b) 2% hexyl resorcinol in an amount of from about 1 to about 20 weight percent;
(c) 1% hydrocortisone in an amount of from about 1 to about 20 weight percent; and
(d) an emollient which comprises cholesterol, stearyl alcohol, wax and white petrolatum, and wherein the medicinal composition is non-irritating and is formulated as a topical application.